Delivery Order SPE2DB22D1106-SPE2DB24FEYK7

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of epinephrine 0.3 mg auto-injectors (4565005899). The $1,513.50 firm-fixed price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, has a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,786.95 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,536,694 units of epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.3 mg auto-injectors. The $1,353.88 firm fixed-price delivery order has an ultimate completion date of August 1, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of epinephrine 0.3 mg auto-injectors. The $1,150.20 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical to support the Department of Defense (DoD). Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the provision of epinephrine 0.15 mg auto-injectors to the U.S. government. The Delivery Order, valued at $2,678.73, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) and has a completion date of June 14, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The Delivery Order contract, valued at $1,814.54, has a firm fixed-price pricing type and an ultimate completion date of July 10, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,237.34 firm fixed price delivery order is for the supply of epinephrine 0.3 mg auto-injector devices, with a period of performance through June 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of epinephrine 0.3 mg auto-injectors. The $1,495.30 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) on June 13, 2023, with a completion date of June 14, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,385,326 units of epinephrine 0.3 mg auto-injectors over a 2-year period ending on April 25, 2024. The $1,917.00 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics and acquisition services to the U.S. Armed Forces. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $1,196.24 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,702,417 units of Epinephrine 0.3 mg auto-injectors. This contract has a completion date of May 24, 2024 and is not set aside. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a range of pharmaceutical...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEYK7
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, is for the delivery of Epinephrine 0.3 mg auto-injectors. The $1,218.77 firm fixed price delivery order, awarded by the Defense Logistics Agency (DLA), has a completion date of June 25, 2024. The contract is not set-aside.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also has a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/23/24, 9:49 AM